Teijin Ltd. engages in the management of its group companies that are involved in the environment and energy, safety and protection, information and electronics, transportation, and healthcare businesses. It operates through the following segments: Materials, Healthcare, and Others. The Materials segment handles the manufacture and sale of polyester, aramid, and carbon fiber products as well as plastic and resin products from polycarbonate resin and polyester film. The Healthcare segment deals with the manufacture and sale of pharmaceuticals and home medical equipment. It also provides home healthcare services. The Others segment offers information technology services. The company was founded by Seita Kumura, Itsuzo Hata, and Naokichi Kaneko on June 17, 1918 and is headquartered in Osaka, Japan.

Senju Pharmaceutical Beijing Co. Ltd., part of Senju Pharmaceutical Co., Ltd., is a company headquartered in Beijing, China, that manufactures and distributes pharmaceuticals.

Meiji Seika Pharma Co., Ltd. engages in the business of manufacture and distribution of pharmaceutical products. It also engages in the animal health business. The company was founded on October 9, 1916 and is headquartered in Tokyo, Japan.

Wholesales pharmaceutical products

Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH is a German private company located in Cologne. The firm manufactures pharmaceutical products. It was founded in 1826 by Maria Clementine. Hans-Helmut Fabry is currently the CEO of the company.

Sinopharm Dezhong (Foshan) Pharmaceutical Co., Ltd. is a pharmaceutical company in China. It offers herbal formulated medicine in forms of pills, tablets, creams & syrup. The company was founded in November 1998 and is headquartered in Guangdong, CN.

Alcon Pharmaceuticals Ltd. supplies pharmaceuticals products. The company is headquartered in Fribourg, Switzerland.

Develops and manufactures ophthalmic pharmaceutical products

Puyi (Shanghai) Biotechnology Co., Ltd. is a Chinese company located in Shanghai. The firm engages in research and development of biodegradable biopolymer materials and manufactures medical devices. It was founded in 2012 by Jian Xie.\nThe company says this about itself: Puyi (Shanghai) Biotechnology Co., Ltd. was established in October 2012. With its core technology focused on material science and drug delivery, Puyi Biotechnology engages in the R&D and commercialization of innovative, high-value and minimally invasive medical devices across multiple market segments. With its values founded on innovation, evidence based research, teamwork and sharing, Puyi Biotechnology will continue to launch more innovative medical products to meet clinical needs.

Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan.

Changchun Dexin Photoelectric Technology Co., Ltd., established on 2005-05-13, The business scope includes laser optics, optoelectronic components and optical,machine,Research on Electrically Integrated Instruments and Equipment,to develop,Production(To operate during the validity period of the license),Sales and technical consultation,Technical Services,technology transfer,Safety Technology Prevention Engineering Construction;computer software development*

Mufei Tongchuang (Chongqing) Technology Co., Ltd., established on 2020-01-06, Business scope includes licensed projects:Production of Class II Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Daily necessities sales;Clothing and apparel retail;Cosmetics Retail;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Information Consulting Service(Not including licensing information consulting services);Conference and Exhibition Services;Data processing and storage support services;Information system integration service;Artificial intelligence application software development;Information Technology Consulting Services;Daily necessities wholesale;General merchandise sales;Maternal and baby products manufacturing;Maternal and baby products sales;AI Hardware Sales;internet sales(Except for products that require a license for sale);electronics sales;Sales of Class I Medical Devices;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Optowell Co,., Ltd. engages in the provision of element manufacturing and packages. Its products include sensors and datacoms. The company was founded on May 10, 2000 and is headquartered in Jeonju, South Korea.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Daiichi Sankyo Healthcare Co., Ltd. engages manufacture and sale of pharmaceutical products. It produces and supplies over-the-counter drugs, quasi drugs, cosmetics, medical equipment, food, and beverages. The company was founded on December 16, 2005 and is headquartered in Tokyo, Japan.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Beijing Kangjiantong Technology Development Co., Ltd., established on 1999-12-22, Business scope includes production of medical devices Ⅱ(by<Medical Device Manufacturing Enterprise License>Approved scope shall prevail)(Limited to branch operations);Sales of medical devices Class II(by<Medical device operating enterprise license>Approved scope shall prevail);technology development,technology transfer,technical consulting,Technical Services;Import and export,Technology Import and Export,Agent import and export;Sales of medical devices(Class I),communication equipment,computer,Software and Auxiliary Equipment,Wujinjiaodian,building materials,stationery,Clothing and shoes,Groceries,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals).(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)